Kexin Huang

CL
h-index18
3papers
50citations
Novelty23%
AI Score35

3 Papers

15.5CLNov 10, 2023Code
Fake Alignment: Are LLMs Really Aligned Well?

Yixu Wang, Yan Teng, Kexin Huang et al.

The growing awareness of safety concerns in large language models (LLMs) has sparked considerable interest in the evaluation of safety. This study investigates an under-explored issue about the evaluation of LLMs, namely the substantial discrepancy in performance between multiple-choice questions and open-ended questions. Inspired by research on jailbreak attack patterns, we argue this is caused by mismatched generalization. That is, LLM only remembers the answer style for open-ended safety questions, which makes it unable to solve other forms of safety tests. We refer to this phenomenon as fake alignment and construct a comparative benchmark to empirically verify its existence in LLMs. We introduce a Fake alIgNment Evaluation (FINE) framework and two novel metrics--Consistency Score (CS) and Consistent Safety Score (CSS), which jointly assess two complementary forms of evaluation to quantify fake alignment and obtain corrected performance estimation. Applying FINE to 14 widely-used LLMs reveals several models with purported safety are poorly aligned in practice. Subsequently, we found that multiple-choice format data can also be used as high-quality contrast distillation-based fine-tuning data, which can strongly improve the alignment consistency of LLMs with minimal fine-tuning overhead. For data and code, see https://github.com/AIFlames/Fake-Alignment.

1.2QMSep 16, 2025
Unleashing the power of computational insights in revealing the complexity of biological systems in the new era of spatial multi-omics

Zhiwei Fan, Tiangang Wang, Kexin Huang et al.

Recent advances in spatial omics technologies have revolutionized our ability to study biological systems with unprecedented resolution. By preserving the spatial context of molecular measurements, these methods enable comprehensive mapping of cellular heterogeneity, tissue architecture, and dynamic biological processes in developmental biology, neuroscience, oncology, and evolutionary studies. This review highlights a systematic overview of the continuous advancements in both technology and computational algorithms that are paving the way for a deeper, more systematic comprehension of the structure and mechanisms of mammalian tissues and organs by using spatial multi-omics. Our viewpoint demonstrates how advanced machine learning algorithms and multi-omics integrative modeling can decode complex biological processes, including the spatial organization and topological relationships of cells during organ development, as well as key molecular signatures and regulatory networks underlying tumorigenesis and metastasis. Finally, we outline future directions for technological innovation and modeling insights of spatial omics in precision medicine.

15.7LGJun 30, 2024Code
TrialBench: Multi-Modal Artificial Intelligence-Ready Clinical Trial Datasets

Jintai Chen, Yaojun Hu, Mingchen Cai et al.

Clinical trials are pivotal for developing new medical treatments but typically carry risks such as patient mortality and enrollment failure that waste immense efforts spanning over a decade. Applying artificial intelligence (AI) to predict key events in clinical trials holds great potential for providing insights to guide trial designs. However, complex data collection and question definition requiring medical expertise have hindered the involvement of AI thus far. This paper tackles these challenges by presenting a comprehensive suite of 23 meticulously curated AI-ready datasets covering multi-modal input features and 8 crucial prediction challenges in clinical trial design, encompassing prediction of trial duration, patient dropout rate, serious adverse event, mortality rate, trial approval outcome, trial failure reason, drug dose finding, design of eligibility criteria. Furthermore, we provide basic validation methods for each task to ensure the datasets' usability and reliability. We anticipate that the availability of such open-access datasets will catalyze the development of advanced AI approaches for clinical trial design, ultimately advancing clinical trial research and accelerating medical solution development.